Sort
8,912 grants matching “sars cov 2”
Development of Brain MRI Contrast Agents
$1,445,351Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Telemedicine and health disparities among community-dwelling older adults with ADRD during COVID-19 pandemic
$1,445,150Shubing Cai · University Of Rochester · RF1 · FY2021 · AG
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,443,819Stanley Perlman · University Of Iowa · P01 · FY2008 · AI
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,443,818Stanley Perlman · University Of Iowa · P01 · FY2007 · AI
LITE CONNECT: Addressing testing gaps and epidemiologic disparities of COVID-19 amongtransgender people in the United States
$1,443,647Andrea L Wirtz · Johns Hopkins University · UH3 · FY2020 · AI
Using Big Data to Help Inform SARS-CoV-2 Therapeutics Development
$1,443,536National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients
$1,442,898William Werbel · Johns Hopkins University · R01 · FY2025 · AI
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,441,647Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2021 · IP
Surveillance for Vaccine Preventable Disease in Children
$1,441,647Julie Anne Boom · Baylor College Of Medicine · U01 · FY2021 · IP
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$1,441,647Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2021 · IP
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,441,646Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,441,645Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2021 · IP
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$1,441,645Janet A Englund · Seattle Children'S Hospital · U01 · FY2021 · IP
Coronavirus Challenge Core
$1,441,507Matthew Bryan Frieman · Washington University · P01 · FY2022 · AI
MFB: Massively parallel identification of translation regulatory sequences in human and viral mRNAs
$1,440,000Carson Thoreen · Yale University · · FY2024 · BIO
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,439,918Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
PPE Request
$1,438,731Lawrence Corey · Fred Hutchinson Cancer Center · S10 · FY2023 · AI
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,438,128University Of Iowa · P01 · FY2005 · AI
Center for Suicide Research and Prevention - Methods Core
$1,437,918Andrea Sarah Foulkes · Massachusetts General Hospital · P50 · FY2023 · MH
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,435,214Kara W Chew · University Of California Los Angeles · U01 · FY2024 · AI
Innate Immunity and Viral Infection in Asthma
$1,433,547Monica Kraft · University Of Arizona · U19 · FY2021 · AI
Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring
$1,431,755Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2024 · HD
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2023 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2022 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2025 · AI